Cite
MLA Citation
William O'Riordan et al.. “Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens.” Open forum infectious diseases, vol. 4, n.d., p. S532. http://access.bl.uk/ark:/81055/vdc_100151521573.0x000038